|
| LogID |
Title |
Initial |
Date |
| AF001 |
Codebook for GA341 (= YJC AE538 = YMU RNA-seq on OKB2/S1F/THP1) |
SFL |
10/21/15 |
| AF002 |
Experimental sheme for AE592 (YMU RNA-seq GA416 and GA417) |
SFL |
10/23/15 |
| AF003 |
Codebook for GA417 |
SFL |
11/3/15 |
| AF004 |
Codebook for GA416 |
SFL |
11/4/15 |
| AF005 |
Codebook for Po-Ting |
SFL |
11/5/15 |
| AF006 |
Codebook for tidy 40T/N raw data (2015_1110_11SVA_40TN_raw = 40TNRaw) |
SFL |
11/10/15 |
| AF007 |
|
SFL |
|
#1由 sufang 在 二, 11/10/2015 – 10:59 發表。 AE901 Annotations for GA416 and GA417
|
(GA417) Long non-coding RNAs (lncRNA) in EBV/KSHV reactivation
| GA417 |
Cell ID |
Dox-inducible genes (24h) |
viral genomes (accession no) |
| SFL1 |
293TetLuc_D24 |
luciferase |
– |
| SFL2 |
293TetER_D24 |
EBV Rta |
– |
| SFL4 |
EREV8_D24 |
EBV Rta |
EBV (akata, KC207813.1) |
| SFL5 |
ERKV_D24 |
EBV Rta |
KSHV (JSC-1, GQ994935.1) |
– HEK293 (ATCC® CRL-1573) human embryonic kidney epithelial cell
– Adenovirus 5 nts 1 to 4344 is integrated into chromosome 19 (19q13.2)
Processing of GA417 in Molas
| Molas |
Implication |
synonym |
| SFL2/SFL1 |
Genes modulated by EBV Rta |
Rta_D24 |
| SFL4/SFL1 |
Genes modulated by EBV Rta during EBV reactivation |
EREV8_D24 |
| SFL5/SFL1 |
Genes modulated by EBV Rta during KSHV reactivation |
ERKV_D24 |
(GA416) Long non-coding RNAs (lncRNA) in EBV infected B cells
| GA416 |
Cell ID |
implication |
viral genomes (access no) |
| 1 |
Akata EBV – ve |
Akata B cell (no EBV) |
– |
| 2 |
Akata EBV – ve_IgG |
Activation of Akata cells with anti-IgG |
– |
| 3 |
Akata EBV +ve |
EBV infected-Akata B cell |
EBV (Akata, KC207813.1) |
| 4 |
Akata EBV +ve_IgG |
Activation of Akata-EBV cells with anti-IgG |
EBV (Akata, KC207813.1) |
| 5 |
T4_B0 |
uninfected B cells (B0) from tonsil |
– |
| 6 |
T4_LCL |
EBV transformed tonsil B cells |
EBV (B95-8, V01555.2) |
| 7 |
B0 |
uninfected cells (B0) |
– |
| 8 |
LCL_B114 |
EBV transformed B cells |
EBV (B95-8, V01555.2) |
Processing of GA416 in Molas
| GA416 |
synonym |
implication |
viral genomes (access no) |
| 2/1 |
Akata_IgG |
Akata_IgG activation |
– |
| 4/2 |
Akata_IgG_EBV |
Akata_IgG_EBV activation |
EBV (Akata, KC207813.1) |
| 3/1 |
Akata_EBV_latent |
EBV transformed Akata cells |
EBV (Akata, KC207813.1) |
| 4/3 |
Akata_EBV_lytic |
Akata_EBV lytic |
EBV (Akata, KC207813.1) |
| 6/5 |
LCL_T4 |
EBV transformed tonsil B cells |
EBV (B95-8, V01555.2) |
| 8/7 |
LCL_B114 |
EBV transformed B cells |
EBV (B95-8, V01555.2) |